Mark Dickman

Employment

• University of Sheffield
  2003 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (159)

• Ion-pair reversed-phase liquid chromatography-mass spectrometry analysis of oligonucleotide therapeutics using fluoroalcohol-free mobile phases
  2026 DOI: 10.26434/chemrxiv.15007460/v1
  +Save
• DNA template heterogeneity and in vitro transcription reaction conditions impact the poly(A) tail length and heterogeneity of mRNA
  2026 DOI: 10.64898/2026.07.02.735822
  +Save
• Automated Online Direct mRNA Sequence Mapping Using Partial RNase T1 Digests
  Analytical Chemistry 2026 DOI: 10.1021/acs.analchem.5c08110
  +Save
• A Universal, AI-based Design Framework for Efficient Manufacturing of mRNA Therapeutics
  2026 DOI: 10.64898/2026.03.09.710039
  +Save
• Analysis of mRNA multimerisation (aggregation) using non-denaturing ion-pair reversed-phase liquid chromatography
  Journal of Chromatography A 2026 DOI: 10.1016/j.chroma.2025.466653
  +Save
• Biophysical characterisation of mRNA structure and its impact on integrity analysis by liquid chromatography and capillary gel electrophoresis methods
  Journal of Chromatography A 2026 DOI: 10.1016/j.chroma.2025.466625
  +Save
• A soft sensor based on pH for real-time monitoring of mRNA medicine production
  Digital Discovery 2026 DOI: 10.1039/D5DD00417A
  +Save
• Analysis of mRNA multimerisation (aggregation) using non-denaturing ion-pair reversed-phase HPLC
  2025 DOI: 10.26434/chemrxiv-2025-54w4w
  +Save
• Glycoprofile comparison of the SARS-CoV-2 spike proteins expressed in CHO and HEK cell lines
  Molecular Biotechnology 2025 DOI: 10.1007/s12033-024-01288-2
  +Save
• Optimisation of Heated Electrospray Ionisation Parameters to Minimise In‐Source Generated Impurities in the Analysis of Oligonucleotide Therapeutics
  Rapid Communications in Mass Spectrometry 2025 DOI: 10.1002/rcm.10033
  +Save